OCT 31, 2016 07:39 PM PDT

"CaFlux" Test for the Unpredictable Immune System

WRITTEN BY: Kara Marker
Immune responses can be unequal and misguided, resulting in certain conditions like allergies and autoimmune disorders. A new testing method developed by scientists from Thomas Jefferson University provides a brand-new opportunity to predict an individual’s immune response to different antigens.
 A CaFlux plate and the green fluorescent read-out from activated immune cells.
The new testing method, called “CaFlux,” quantifies the strength of the immune response to a particular antigen, like pollen or bacterial components. CaFlux is more sensitive and quicker to yield results than any other similar method to date, and it’s able to test a wide variety of antigenic targets.
 
"A future application of this test could help determine who might respond with a sneeze versus who might respond with anaphylactic shock before it happened,” explained senior author Yuri Sykulev, MD, PhD.
 
The CaFlux process begins with immune cells that are known to respond to potential antigens. A variety of antigens are then flowed over the immune cells to look for immune cell-antigen connections. If an antigen and immune cell pair occurs, the joining of their receptors triggers the influx of calcium through calcium channels, and green fluorescence proteins are activated, detected with a microscope, and measured with image-reading software.
 
The stronger the connection, or the more capable an immune cell is in binding to an antigen, the more calcium ions that can flow into the cell through the channels, and the brighter the glow of green fluorescent protein. Quite the opposite happens when a weaker match occurs: less calcium and a much dimmer glow.
 
CaFlux can accurately depict the number of T lymphocytes that respond in each sample of antigens, as well as how powerfully and how quickly each cell responds to antigen. The applications for CaFlux in the clinical setting are numerous; doctors could potentially be able to predict how an individual would react to certain antigens. This could help doctors decide treatment options for patients considering organ transplantation, those with autoimmune disease and allergies, and individuals with cancer.
 
To test CaFlux in a real-life setting, researchers used T lymphocytes from a bone marrow transplant recipient, testing for immune cell reactivity to cytomegalovirus (CMV). Infections from cytomegalovirus rarely cause problems in people with healthy immune systems, but they can be deadly for immunocompromised people, like those who receive immunosuppressants before a bone marrow transplant.
 
The CaFlux results showed a slow and weak T lymphocyte response to CMV antigens, suggesting that the individual’s immune system was not prepared to fight off a CMV infection.
 
"That weak response was mirrored by what happened in the clinic," said oncologist Neal Flomenberg. "The patient's CMV reactivated while the immune system was still rebooting and unable to mount a strong response against CMV, and he had to be treated for the infection. Had we been able to monitor this patient's immune system's ability to respond to CMV, we may have been able to tailor his treatment to better keep the CMV in check."
 
The new CaFlux test could help doctors avoid dangerous situations by knowing ahead of time how one patient might respond to certain immune targets. The current study was published in the journal Nature Communications.
 


Source: Thomas Jefferson University
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 08, 2018
Immunology
MAY 08, 2018
Nuclear Pore Complexes Vital for T Cell Survival
What’s happening on the molecular level that ensures protective T cells of the immune system will do their job? A new study from Sanford-Burnham Preb...
MAY 10, 2018
Immunology
MAY 10, 2018
New Biomarker for Lung Cancer Diagnosis
Lung cancer is the most common cause of death from cancer for both genders and for people all over the globe. This is largely due to the lack of diagnostic...
JUN 27, 2018
Immunology
JUN 27, 2018
Immune Cells Responsible for Chemo-induced Diarrhea
While studying specific immune cells in the context of chronic itching in the skin, two Washington University School of Medicine scientists discovered that...
JUL 03, 2018
Immunology
JUL 03, 2018
Here's a Virus that Boosts the Immune System
There’s a new therapeutic approach to boosting the weakened immune system that develops naturally with age, but it’s anything but conventional....
AUG 25, 2018
Immunology
AUG 25, 2018
Maternal Depression Alters Mom and Baby's Immune Markers
Maternal depression alters stress and immune system biomarkers in children leading to social withdrawal and behavioral problems....
AUG 31, 2018
Immunology
AUG 31, 2018
B Cells Control Connective Tissue Disorder Scleroderma
Effector and Regulatory B cells play reciprocal role in pathogenesis of scleroderma....
Loading Comments...